| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.32 | 1e-10 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-08 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.29 | 3e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 7e-05 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |